When you hear stomach cancer, you may assume that all tumours in the stomach behave the same way. However, it is not true. Gastrointestinal stromal tumours, or GISTs, are a rare and distinct type of ...
GISTs are solid tumors, primarily in the stomach, characterized by KIT and EGFR mutations, with Gleevec as a key treatment. Recent advancements in GIST treatment include multiple TKIs, such as Sutent, ...
These study authors hope their findings will inform future research on gastrointestinal stromal tumors (GIST) and close care gaps for minority patient populations. Unfavorable trends in the diagnosis ...
GIST originates in stromal tissue, differentiating it from epithelial-based GI cancers, and is classified as a sarcoma. Symptoms include fullness, fatigue, and GI bleeding, necessitating awareness and ...
Gastrointestinal stromal tumors (GISTs) have increased in incidence over the past two decades, with notable survival disparities among racial and ethnic groups, particularly among Black patients who ...
Gastrointestinal stromal tumors (GISTs) are the most common type of sarcoma, often driven by mutations in the KIT or PDGFRA genes. Tyrosine kinase inhibitors (TKIs) like imatinib have been the ...
A recent study offering a comprehensive view of the genome and transcriptome of gastrointestinal stromal tumors (GISTs) has introduced a new, multi-omics-based molecular classification of these tumors ...
A newly developed liver metastasis mouse model shows that the gap junction protein Connexin 43, highly expressed in small intestinal GISTs, enhances hepatic metastatic potential in vivo while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results